News

The first sign of multiple myeloma varies by person and may not occur until a later stage of the disease. Learn how to ...
Scans of the man's affected hand and foot revealed "destructive lytic lesions that had completely replaced" the bones in the tips of the middle finger and big toe. Lytic lesions are areas where bone ...
Multiple myeloma (MM) remains a complex and heterogeneous hematologic malignancy with evolving therapeutic challenges. In recent years, immunotherapy has ...
Friends and family share memories and stories about the Kentucky-based trainer who passed away at the age of 73 July 15 after a long battle with cancer ...
Moving tributes to former Kentucky-based trainer from the wrong side of the tracks fought a valiant 15-year battle with ...
Tony Newberne is a high-risk multiple myeloma survivor. He is also a CPT, dietary manager, and patient advocate for several ...
I’ve endured numerous rounds of radiation and taken thousands of pills—but CAR-T is the most effective therapy I’ve completed ...
Can multiple myeloma be prevented? Experts agree that most cases of multiple myeloma are not linked to an avoidable risk.
The median age at diagnosis is 70. Multiple myeloma is almost always preceded by an asymptomatic premalignant stage known as monoclonal gammopathy of undetermined significance (MGUS).
Early intervention in high-risk smoldering myeloma with lenalidomide delays progression by up to 7 years and achieves sustained MRD negativity in one third of patients.
Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without detectable cancer for years after facing certain death.
A breakthrough in cancer treatment in the Valley: CARVYKTI therapy is helping Arizonans with multiple myeloma live longer, healthier lives.